Norman James G, Politz Douglas E
Norman Endocrine Surgery Clinic, Tampa, Florida 33613, USA.
Endocr Pract. 2007 Mar-Apr;13(2):105-13. doi: 10.4158/EP.13.2.105.
To evaluate the safety of immediate discharge after parathyroidectomy and to establish a protocol for the amount and duration of supplemental orally administered calcium for patients with varied clinical presentations of primary hyperparathyroidism.
A 40-months, prospective, single institution, cohort study of 3,000 consecutive patients undergoing parathyroidectomy and discharged within 2.5 hours after the operation is reviewed. The amount of oral calcium supplementation prescribed postoperatively varied according to a protocol that considered the degree of serum calcium elevation preoperatively as well as the intraoperative findings (hyperplasia versus adenoma). Symptoms of hypocalcemia were tracked, and all surgical outcomes were monitored.
With use of the reported protocol, less than 7% of patients had postoperative symptoms of hypocalcemia, most of whom were successfully self-treated with additional orally administered calcium. Only 6 patients (0.2%) required a visit to the emergency department for intravenous calcium infusion, all occurring on postoperative day 3 or later, and none of these patients required rehospitalization. Postoperative calcium requirements varied on the basis of the degree of serum calcium elevation preoperatively, number of parathyroid glands removed or subjected to biopsy, presence of morbid obesity, and presence of severe osteoporosis.
Patients with primary hyperparathyroidism can be sent home immediately after successful parathyroidectomy, provided specific measures are taken regarding postoperative oral calcium supplementation. Use of a specific calcium dosing protocol that considers several patient variables will prevent the postoperative development of symptomatic hypocalcemia in 93% of patients, identify patients at high risk of hypocalcemia, and allow most patients who develop symptoms of hypocalcemia to self-medicate in a simple and predictable fashion. Routine monitoring of postoperative serum calcium levels in the hospital can be safely eliminated if the details of this protocol are followed.
评估甲状旁腺切除术后立即出院的安全性,并为原发性甲状旁腺功能亢进不同临床表现的患者制定口服补充钙剂的剂量和疗程方案。
回顾一项为期40个月的前瞻性单机构队列研究,该研究纳入了3000例连续接受甲状旁腺切除术且术后2.5小时内出院的患者。术后口服钙剂的补充量根据一项方案进行调整,该方案考虑了术前血清钙升高的程度以及术中发现(增生与腺瘤)。追踪低钙血症症状,并监测所有手术结果。
采用所报告的方案,不到7%的患者有术后低钙血症症状,其中大多数患者通过额外口服钙剂成功进行了自我治疗。只有6例患者(0.2%)因需要静脉输注钙剂而前往急诊科就诊,均发生在术后第3天或更晚,且这些患者均无需再次住院。术后钙剂需求量因术前血清钙升高程度、切除或活检的甲状旁腺数量、病态肥胖的存在以及严重骨质疏松的存在而有所不同。
原发性甲状旁腺功能亢进患者在甲状旁腺切除成功后可立即出院,前提是采取了关于术后口服钙剂补充的具体措施。使用考虑多个患者变量的特定钙剂给药方案可防止93%的患者术后出现有症状的低钙血症,识别低钙血症高危患者,并使大多数出现低钙血症症状的患者能够以简单且可预测的方式进行自我治疗。如果遵循该方案的细节,可安全地取消在医院对术后血清钙水平的常规监测。